Yayın: Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?
| dc.contributor.author | Gülbaş, Zafer | |
| dc.contributor.author | Sevgi Işık | |
| dc.contributor.author | Hava Üsküdar Teke | |
| dc.contributor.author | Abdülvahap Aslan | |
| dc.contributor.author | Filiz Yavaşoğlu | |
| dc.contributor.author | Zafer Gülbaş | |
| dc.contributor.author | Fatih Demırkan | |
| dc.contributor.author | Hülya Özen | |
| dc.contributor.author | Oğuz Cilingir | |
| dc.contributor.author | Nur Sena Inci | |
| dc.contributor.author | Gülçin Günden | |
| dc.contributor.author | Tuba Bulduk | |
| dc.contributor.author | Ebru Erzurumluoğlu Gökalp | |
| dc.contributor.author | Sinem Kocagil | |
| dc.contributor.author | Sevilhan Artan | |
| dc.contributor.author | Olga Meltem Akay | |
| dc.contributor.orcid | 0000-0003-1881-1912 | |
| dc.contributor.orcid | 0000-0003-0243-784X | |
| dc.contributor.orcid | 0000-0002-4434-4580 | |
| dc.contributor.orcid | 0000-0002-4709-0627 | |
| dc.contributor.orcid | 0000-0002-1172-8668 | |
| dc.contributor.orcid | 0000-0003-4144-3732 | |
| dc.contributor.orcid | 0000-0003-1984-1494 | |
| dc.contributor.orcid | 0000-0003-1707-1764 | |
| dc.contributor.orcid | 0000-0001-9549-5904 | |
| dc.contributor.orcid | 0000-0002-1275-5174 | |
| dc.contributor.orcid | 0000-0003-2595-3919 | |
| dc.contributor.orcid | 0000-0001-7658-6309 | |
| dc.contributor.orcid | 0000-0002-6759-1939 | |
| dc.date.accessioned | 2025-11-13T10:15:10Z | |
| dc.date.issued | 2021-01-06 | |
| dc.identifier.doi | https://doi.org/10.1186/s13039-020-00522-1 | |
| dc.identifier.endpage | 2 | |
| dc.identifier.issn | 1755-8166 | |
| dc.identifier.issue | 1 | |
| dc.identifier.openalex | W3119940669 | |
| dc.identifier.startpage | 2 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3587 | |
| dc.identifier.uri | https://doi.org/10.1186/s13039-020-00522-1 | |
| dc.identifier.volume | 14 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Molecular Cytogenetics | |
| dc.rights | openAccess | |
| dc.subject | Stage (stratigraphy) | |
| dc.subject | Cytogenetics | |
| dc.subject | Internal medicine | |
| dc.subject | Multivariate analysis | |
| dc.subject | Biology | |
| dc.subject | Disease | |
| dc.subject | Survival analysis | |
| dc.subject | Oncology | |
| dc.subject | Gene | |
| dc.subject | Medicine | |
| dc.subject | Genetics | |
| dc.subject | Chromosome | |
| dc.title | Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion? | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5058571002 |